United Therapeutics Corporation
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2025
Total Assets: $7.88B
Liabilities Breakdown FY2025
Total Liabilities: $783.8M
Asset Breakdown
Total Assets: $7.88B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.56B | 19.8% |
| Accounts Receivable | $350.2M | 4.4% |
| Inventory | $183.1M | 2.3% |
| Property, Plant & Equipment | $1.73B | 22.0% |
| Goodwill | $32.3M | 0.4% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $4.03B | 51.1% |
Liabilities Breakdown
Total Liabilities: $783.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $7.1M | 0.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $776.7M | 99.1% |